Novel TIA biomarkers identified by mass spectrometry-based proteomics.
about
Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients.Blood Biomarkers in Minor Stroke and Transient Ischemic Attack.Prevention and protection against cerebral ischemic injury using acupuncture.Discovery and Longitudinal Evaluation of Candidate Biomarkers for Ischaemic Stroke by Mass Spectrometry-Based Proteomics.Proteomic approaches in microalgae: perspectives and applications.
P2860
Novel TIA biomarkers identified by mass spectrometry-based proteomics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Novel TIA biomarkers identified by mass spectrometry-based proteomics.
@en
Novel TIA biomarkers identified by mass spectrometry-based proteomics.
@nl
type
label
Novel TIA biomarkers identified by mass spectrometry-based proteomics.
@en
Novel TIA biomarkers identified by mass spectrometry-based proteomics.
@nl
prefLabel
Novel TIA biomarkers identified by mass spectrometry-based proteomics.
@en
Novel TIA biomarkers identified by mass spectrometry-based proteomics.
@nl
P2093
P2860
P356
P1476
Novel TIA biomarkers identified by mass spectrometry-based proteomics.
@en
P2093
Calvin J Kuo
Christopher M Adams
Gregory W Albers
Jean-Marc Olivot
Michael Mlynash
P2860
P304
P356
10.1111/IJS.12603
P577
2015-08-26T00:00:00Z